Endogenous expression of HLA-G and/or HLA-E by mesenchymal cells
US8647871B2 · kind B2 · utility
6Cited by
1References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 28, 2008 |
| Grant date | Feb 11, 2014 |
| Priority date | — |
| Expiry date | Jul 29, 2028 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/56977
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions are provided for the identification and isolation of mammalian HLA-G+ MSC, HLA-E+ MSC, or HLA-G4VHLA-E+ MSC. The methods of the invention provide a means to obtain enriched HLA-G+ MSC, HLA-E+ MSC, or HLA-G+/HLA-E+ MSC populations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.